astrazeneca hit by drug failure shares in anglo swedish drug have closed down 8% in uk trade after the failure of its iressa drug in a major clinical trial.the lung cancer drug did not significantly prolong survival in patients with the disease.tarceva made by osi pharmaceuticals, genentech and roche has already proved to be successful in helping prolong the life of lung cancer patients.the company said mr patterson would make substantial changes to the clinical organisation and its processes .i am determined to improve our development and regulatory performance, restore confidence in the company and value to shareholders, said chief executive tom mckillop.